Nasal spray for seasonal allergy facial symptoms
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at how seasonal allergies affect the face in adults. It tests a nasal spray and uses facial photos to see how well it works and how it changes allergy symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had seasonal allergies (like hay fever) in the past 2 years.
- You must be willing to use a nasal spray during the study.
- You must have visible allergy symptoms on your face, like dark circles under the eyes or redness.
- You must agree to have photos taken of your face and allow them to be used for promotional purposes.
- If you are female and could become pregnant, you must have a negative pregnancy test and use birth control during the study.
- You must be in generally good health, with no serious medical conditions like glaucoma, cataracts, or asthma requiring daily steroid medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new nasal spray (ALDP001) in adults with seasonal allergies to ragweed. It aims to find the best dose and how often to use it.
This trial tests a new nasal spray designed to relieve the stuffy nose, sneezing, and itching caused by seasonal allergies. It is for people with moderate to severe symptoms that aren’t controlled by other treatments.
This trial tests whether PL-14, a new nasal spray, works better than saline spray at relieving seasonal allergy symptoms like sneezing, itching, and congestion. If it works well and is safe, it could offer patients a new way to manage allergies during pollen season.
This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.
This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.
This study tests an investigational injection (GR1802) that may help reduce seasonal allergy symptoms when standard allergy medications aren't enough. If you qualify, you'll receive the injection during the pollen season to see if it improves your sneezing, runny nose, and itchy eyes.
Hear when a new Rhinitis Allergic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.